News About: Pharm. Industry
Green Cross sets overseas sales target at $100 million
Green Cross Corporation, the leading Korean drug manufacturer, has set its sales target at $100 million abroad this year, according to the company.
“We set this year’s overseas sales target at $100 million at up 25...
32 firms’ operating profits fall in 2011
Korea's 32 drug firms posting more than 100 billion won in annual sales saw their operating profits decline in 2011 due to sluggish sales that might be affected by the government’s aggressive policy to eliminate the p...
Pharmaceutical firms’ entertainment expenses top 45 billion won in 2011
The dented marketing activities due to the government’s crackdown on illegal rebates last year had pharmaceutical companies scramble to tighten their purse strings, but they perhaps considered entertainment expenses a...
One trillion won fund to be set up for drug companies
Korea has unveiled an ambitious vision to foster global pharmaceutical firms through the creation of a large-scale research and development (R&D) fund in an era of the Korea-U.S. free trade deal.
The Ministry of St...
Shinpoong will open cephalosporin plant at Osung complex
Shinpoong Pharmaceutical Co. will complete its EU-GMP plant next month for production of cephalosporin antibiotics in the form of bulks and finished products at Osung complex to make inroads to the European market to ...
US FDA approves Korea’s oral anti-snoring spray
The U.S. Food and Drug Administration Monday approved an over-the counter oral anti-snoring spray called NoSno spray, following the approval of the Korea Food and Drug Administration.
J&JC, a local trader that make...
Pharmaceutical firms’ promotion expenses down
The government’s drug price cuts of the past year had companies scramble to tighten their purse strings, according to a report released by Yakup.com, a pharmaceutical information company.
The report said that Korea...
Sale of new drug for osteoporosis approved
A newly-developed drug for osteoporosis has received approval for production and sale from the health authorities.
Layla tablets, developed by PMG Korea, has passed safety and effectiveness tests, becoming the seve...
KCTU protest drug firms’ restructuring plan
The Korea Confederation of Trade Unions (KCTU) denounced local drug makers Tuesday for their reconstructing plan, claiming pharmaceutical company should withdrawal their lawsuit action against the government.
The K...
Drugmakers scurry to secure liquidity this year
A growing number of pharmaceutical companies remain vigilant and secure enough liquidity for unfavorable business conditions due to a variety of negative factor that may affect the local pharmaceutical industry.
A ...
